TTR and cardiac amyloidosis: Previous studies have reported the prevalence of wild‐type transthyretin amyloid cardiomyopathy (wtATTR‐CM) increases with age and that prevalence is estimated to be approximately 10%–25% in patients over 80.54, 85, 86